Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
FDA
Eli Lilly
Novo Nordisk
Biotechnology
Pfizer
Gene Therapy
Covid-19
Duchenne Muscular Dystrophy
CRISPR
Vertex Pharmaceuticals
RFK Jr.
Sarepta Therapeutics
Moderna
Drug Pricing
Biotech
Biotech Industry
Obesity
Astrazeneca
Obesity Drugs
Glp-1

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes416Founded8 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

Is the Food and Drug Administration taking inconsistent approaches to Duchenne muscular dystrophy drugs? How will a new batch of drug executives shake up their companies? And why is Adam talking to a recruiter?

We discuss all that and more on this we... more

What does it take to develop a therapy for an ultra-rare disease? What are the allegations against a telehealth company that’s partnered with Novo Nordisk? And has a wanted fugitive been posing as a biotech executive?

We discuss all that and more on... more

On this week’s episode of "The Readout LOUD": The Kalshi prediction markets are coming for biotech, plus the controversy over an experimental Alzheimer’s disease treatment from Biogen.

Kalshi, the maker of prediction markets, announced this week tha... more

Why does getting family health insurance through a job cost as much as buying a new car? How did a whistleblower take on an insurance contractor? And who might be the new Food and Drug Administration commissioner?

We discuss all that and more on thi... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Raising Health
Raising HealthAndreessen Horowitz, a16z Bio + Health

Recent Guests

Jared Baitin
Senior Vice President, Clinical Development and Virology Therapeutic Head at Gilead
Gilead
Episode: 411: Capricor's data clash and a fugitive in the C-suite
Matthew Herper
Colleague and author of the Grace piece
STAT
Episode: 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Matt Wilsey
Father (Grace's father), CEO of Grace Science
Grace Science
Episode: 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Jonathan Kimmelman
Bioethicist at McGill University
McGill University
Episode: 409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Chris Deacon
Attorney; whistleblower whistleblower advocate who exposed overpayments in New Jersey health coverage
Independent
Episode: 408: Whistleblower takes on health insurance and FDA commissioner candidates
Mika Kakafuda-Durink
Senior Vice President, Therapeutic Area Head Oncology
Gilead Sciences
Episode: 407: The mysterious case of Eli Lilly's obesity drug
Galia Levy
Senior Vice President and Global Head of Development
Kite, a Gilead company
Episode: 407: The mysterious case of Eli Lilly's obesity drug
Lauren Holder
Huntington disease advocate; producer and host of the Hope for HD podcast
HD community / Hope for HD
Episode: 406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises
Isabella Cueto
STAT chronic disease reporter
STAT
Episode: 406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises

Hosts

Allison DeAngelis
Host of The Readout Loud
Adam Feuerstein
Co-host of The Readout Loud
Elaine Chen
Host/Co-host of The Readout Loud

Reviews

4.7 out of 5 stars from 593 ratings
  • Constructive Feedback on Episode 398

    Hey STAT Team - As a long time reader and biotech CEO, I wanted to pass on hopefully constructive feedback on your show in general and this specific episode. I really enjoyed hearing the inside scoop from Bryan Roberts on Kelonia and the Lilly deal. That was great. Please do more of that! In the constructive feedback category, the one thing that I would caution you on, both in this episode and others, is the trivial nature (joking, in fact) in how you handle very, very tough times for these comp... more

    Apple Podcasts
    3
    DP75007
    United States3 months ago
  • David Olson

    Thoughtful and concise discussion about drug development processes. I found this illuminating

    and hopeful

    Apple Podcasts
    5
    Auldkirk
    United Kingdom8 months ago
  • Really informative and relevant

    Great coverage by the three hosts.

    Only area of improvement is if the audio editor can adjust the volume for all speakers to be equal because for some reason Elaine’s mic tends to be the loudest and I have to keep adjusting the volume for each speaker.

    Apple Podcasts
    4
    orange03$592
    United States8 months ago
  • Great pod!

    This is a great overview of the biopharm space with an engaging and fun style. I also like the unrelated chat amongst the team, particularly as a fellow fan of the Great British Bake Off, given this is an industry that can often take itself very seriously!

    Apple Podcasts
    5
    123etcetc
    United Kingdom9 months ago
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Informative and accessible biotech coverage with strong guest insights.
Can be polarizing at times; some listeners desire more neutrality and fewer in-jokes.
Engaging, high-credibility reporting from reporters and analysts.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#49
Finland/Business
Apple Podcasts
#196
South Korea/Business

Talking Points

Recent interactions between the hosts and their guests.

409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Q: What are the main ethical concerns Jonathan Kimmelman raises about prediction markets in trials, and how might Kalshi mitigate them?
Kimmelman highlights risks to enrollment, bias in endpoints, and the need to stage rollout so markets don't influence ongoing data collection. He suggests limiting markets to later stages or post-data collection points and emphasizes maintaining trial integrity as a core priority.
409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Q: Kalshi announced it will start taking bets on phase three trial outcomes and FDA approvals—what is your immediate assessment of this and what concerns does it raise?
The answer centers on balancing potential informational value from market-based signals against risks of bias, altered patient and physician behavior, and threats to trial integrity. While markets could provide useful external signals, there are valid worries about enrollment disruption, data noise during lag periods, and the possibility that bets could become self-fulfilling or distort decision-making.
410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Q: Why did you decide to pursue Grace's treatment so aggressively and broadly for others with the same condition?
Wilsey emphasizes a commitment to not treating Grace as an outlier, arguing that helping one child can illuminate a path for many and that the potential benefits for the broader community justify accelerated, carefully monitored development.
408: Whistleblower takes on health insurance and FDA commissioner candidates
Q: Chris, what can employers do ahead of renewals to try to manage rising costs without sacrificing coverage for employees?
She advocates starting reforms earlier, moving beyond traditional renewal cycles, and using data-driven procurement and broader contract structures to address unit costs and high-cost claims.
408: Whistleblower takes on health insurance and FDA commissioner candidates
Q: Chris, how did it feel hearing that the settlement could leave you out of the case and potentially face years of litigation if you didn't sign?
Chris explains that she felt betrayed and treated as a relator whistleblower for years, but emphasizes her decision to speak out despite the outcome, underscoring the personal cost of whistleblowing.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

The show breaks down biotech and health policy news with a lively, accessible style, pairing rapid-fire industry updates with in-depth interviews. Topics frequently center on FDA decisions, M&A activity, high-stakes trial results, and the economics of biotech, including telehealth, pricing, and reimbursement dynamics. A notable strength is the mix of seasoned reporters and industry executives, offering both investigative context and practical takeaways for people working in biotech PR, media, or sponsorships. The format's casual banter, strong reporting, and guest diversity make complex topics approachable while staying policy- and data-driven, which can help potential listeners decide if it fits their interest in biotech startups, pharma s... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. Raising Health
5. Business Of Biotech

How many episodes of The Readout Loud are there?

The Readout Loud launched 8 years ago and published 416 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Jared Baitin
2. Matthew Herper
3. Matt Wilsey
4. Jonathan Kimmelman
5. Chris Deacon
6. Mika Kakafuda-Durink
7. Galia Levy
8. Lauren Holder

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days